DE69109583D1 - Verfahren zur Behandlung von entzündlichen Darmerkrankungen. - Google Patents
Verfahren zur Behandlung von entzündlichen Darmerkrankungen.Info
- Publication number
- DE69109583D1 DE69109583D1 DE69109583T DE69109583T DE69109583D1 DE 69109583 D1 DE69109583 D1 DE 69109583D1 DE 69109583 T DE69109583 T DE 69109583T DE 69109583 T DE69109583 T DE 69109583T DE 69109583 D1 DE69109583 D1 DE 69109583D1
- Authority
- DE
- Germany
- Prior art keywords
- procedure
- treatment
- inflammatory bowel
- bowel diseases
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57228690A | 1990-08-27 | 1990-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69109583D1 true DE69109583D1 (de) | 1995-06-14 |
DE69109583T2 DE69109583T2 (de) | 1995-10-12 |
Family
ID=24287150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69109583T Expired - Fee Related DE69109583T2 (de) | 1990-08-27 | 1991-08-22 | Verfahren zur Behandlung von entzündlichen Darmerkrankungen. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5552439A (de) |
EP (1) | EP0474403B1 (de) |
JP (1) | JPH04230622A (de) |
KR (1) | KR920003968A (de) |
AU (1) | AU642762B2 (de) |
CA (1) | CA2049481A1 (de) |
DE (1) | DE69109583T2 (de) |
ES (1) | ES2071930T3 (de) |
HU (1) | HUT61661A (de) |
ZA (1) | ZA916555B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4204405A1 (de) * | 1991-08-02 | 1993-02-04 | Boehringer Mannheim Gmbh | Verwendung von di-tert.-butylhydroxyphenyl-derivaten zur therapie von entzuendlichen erkrankungen des magen-darm-traktes |
DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
US5633283A (en) * | 1995-01-23 | 1997-05-27 | Eli Lilly And Company | Method for treating multiple sclerosis |
JP3299100B2 (ja) * | 1995-12-05 | 2002-07-08 | 株式会社資生堂 | フェニレンジアミン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤 |
CA2332398A1 (en) * | 1998-05-19 | 1999-11-25 | Ian Irwin | Benzamide therapeutics for the treatment of inflammatory bowel disease |
US6083989A (en) * | 1999-05-18 | 2000-07-04 | Centaur Pharmaceuticals, Inc. | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
AU1917201A (en) * | 1999-11-18 | 2001-05-30 | Centaur Pharmaceuticals, Inc. | Amide therapeutics and methods for treating inflammatory bowel disease |
US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
US6358939B1 (en) | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
US6689788B1 (en) | 2000-08-25 | 2004-02-10 | University Of Florida | Method and composition for treatment of inflammatory bowel disease |
US20030118329A1 (en) * | 2001-12-21 | 2003-06-26 | Pere Obrador | Video indexing using high resolution still images |
IL152127A0 (en) * | 2002-10-06 | 2003-05-29 | Bio Balance Corp | Probiotic compositions for the treatment of inflammatory bowel disease |
EP1722630A4 (de) | 2004-01-20 | 2009-05-27 | Richard F Harty | Zusammensetzungen und verfahren zur behandlung von entzündungskrankheiten |
MX2007012659A (es) | 2005-04-13 | 2008-01-11 | Astex Therapeutics Ltd | Derivados de hidroxi-benzamida y su uso como inhibidores de hsp90. |
US7754725B2 (en) | 2006-03-01 | 2010-07-13 | Astex Therapeutics Ltd. | Dihydroxyphenyl isoindolymethanones |
JP5528807B2 (ja) | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | 複合薬剤 |
EP2073803B1 (de) | 2006-10-12 | 2018-09-19 | Astex Therapeutics Limited | Pharmazeutische kombinationen |
JP5410285B2 (ja) | 2006-10-12 | 2014-02-05 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
EP2073804B1 (de) | 2006-10-12 | 2017-09-13 | Astex Therapeutics Limited | Hydroxy-substituierte benzoesäureamid-verbindungen zur verwendung in der behandlung von schmerzen |
EP2073802A1 (de) | 2006-10-12 | 2009-07-01 | Astex Therapeutics Limited | Pharmazeutische kombinationen |
GB0620259D0 (en) | 2006-10-12 | 2006-11-22 | Astex Therapeutics Ltd | Pharmaceutical compounds |
US7923014B2 (en) * | 2007-02-12 | 2011-04-12 | The Board Of Regents Of The University Of Texas System | Expression and purification of HIP/PAP and uses therefor |
GB0806527D0 (en) | 2008-04-11 | 2008-05-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
WO2010042933A2 (en) | 2008-10-10 | 2010-04-15 | Northwestern University | Inhibition and treatment of prostate cancer metastasis |
WO2016073897A1 (en) | 2014-11-06 | 2016-05-12 | Northwestern University | Inhibition of cancer cell motility |
US10449198B2 (en) | 2016-07-01 | 2019-10-22 | The University Of Liverpool | Method for treating pain |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3043774A (en) * | 1955-09-23 | 1962-07-10 | Ethyl Corp | Organic compositions |
NL281258A (de) * | 1961-07-28 | 1900-01-01 | United States Rubber Co | |
US3305483A (en) * | 1964-12-03 | 1967-02-21 | Ethyl Corp | Stabilized organic compositions |
US3809761A (en) * | 1970-03-12 | 1974-05-07 | Ethyl Corp | Method for reducing plasma lipid levels |
US3792170A (en) * | 1972-03-14 | 1974-02-12 | Merck & Co Inc | Novel alkylsulfinyl derivatives for pain,fever and inflammation |
DE2240609A1 (de) * | 1972-08-18 | 1974-02-28 | Hoechst Ag | Stoffwechselwirksame derivate der 4-hydroxy-3,5-di-alkylphenyl-propionsaeure |
US4073942A (en) * | 1972-10-23 | 1978-02-14 | Boehringer Ingelheim Gmbh | Halo-substituted hydroxybenzyl-amines as secretolytic agents |
GB1405767A (en) * | 1972-12-14 | 1975-09-10 | Ethyl Corp | Method formulation and pharmaceutical composition for reducing plasma lipid levels |
US3994828A (en) * | 1973-06-07 | 1976-11-30 | Dynapol Corporation | Nonabsorbable antioxidant |
US4116930A (en) * | 1975-11-03 | 1978-09-26 | Ciba-Geigy Corporation | Pyromellitic dimiides of 3,5-dialkyl-4-hydroxyphenylsubstituted amines |
US4128664A (en) * | 1977-05-16 | 1978-12-05 | Riker Laboratories, Inc. | Substituted benzamides as anti-inflammatory agents |
US4324717A (en) * | 1980-06-23 | 1982-04-13 | The B. F. Goodrich Company | Norbornene polymers stabilized with hindered aromatic alcohols |
US4562201A (en) * | 1982-07-26 | 1985-12-31 | American Hospital Supply Corporation | Aminomethyl benzanilides |
JPS6061523A (ja) * | 1983-09-16 | 1985-04-09 | Shionogi & Co Ltd | 経口用ドブタミン製剤 |
US4532356A (en) * | 1983-11-16 | 1985-07-30 | Ethyl Corporation | Chemical process |
GB8501646D0 (en) * | 1985-01-23 | 1985-02-27 | Nipa Lab Ltd | Control of micro-organisms |
US4959503A (en) * | 1986-04-11 | 1990-09-25 | Warner-Lambert Company | Diarylalkanoids having activity as lipoxygenase inhibitors |
US4708966A (en) * | 1986-06-27 | 1987-11-24 | The Procter & Gamble Company | Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation |
IT1204416B (it) * | 1986-06-27 | 1989-03-01 | Midy Spa | Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini |
DE3702755A1 (de) * | 1987-01-30 | 1988-08-11 | Hoechst Ag | 3,5-di-tert.-butyl-4-hydroxybenzoesaeureamid, verschiedene von dessen derivaten, verfahren zur herstellung dieser verbindungen, die sie enthaltenden arzneimittel und ihre verwendung |
US4948813A (en) * | 1987-11-30 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Benzylketone phospholipase A2 inhibitors |
DE3903989A1 (de) * | 1989-02-10 | 1990-09-20 | Basf Ag | Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika |
EP0385043A1 (de) * | 1989-02-28 | 1990-09-05 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) | 4-Substituierte Piperazinderivate |
-
1991
- 1991-08-19 CA CA002049481A patent/CA2049481A1/en not_active Abandoned
- 1991-08-19 ZA ZA916555A patent/ZA916555B/xx unknown
- 1991-08-22 ES ES91307722T patent/ES2071930T3/es not_active Expired - Lifetime
- 1991-08-22 DE DE69109583T patent/DE69109583T2/de not_active Expired - Fee Related
- 1991-08-22 EP EP91307722A patent/EP0474403B1/de not_active Expired - Lifetime
- 1991-08-23 AU AU82782/91A patent/AU642762B2/en not_active Ceased
- 1991-08-24 KR KR1019910014710A patent/KR920003968A/ko not_active Application Discontinuation
- 1991-08-26 JP JP3213538A patent/JPH04230622A/ja not_active Withdrawn
- 1991-08-26 HU HU912792A patent/HUT61661A/hu unknown
-
1993
- 1993-09-29 US US08/129,003 patent/US5552439A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69109583T2 (de) | 1995-10-12 |
US5552439A (en) | 1996-09-03 |
AU8278291A (en) | 1992-03-05 |
HUT61661A (en) | 1993-03-01 |
HU912792D0 (en) | 1992-01-28 |
CA2049481A1 (en) | 1992-02-28 |
ES2071930T3 (es) | 1995-07-01 |
EP0474403B1 (de) | 1995-05-10 |
EP0474403A1 (de) | 1992-03-11 |
AU642762B2 (en) | 1993-10-28 |
JPH04230622A (ja) | 1992-08-19 |
KR920003968A (ko) | 1992-03-27 |
ZA916555B (en) | 1993-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69109583T2 (de) | Verfahren zur Behandlung von entzündlichen Darmerkrankungen. | |
ATE241977T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen | |
DE69004081T2 (de) | Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen. | |
DE69124293T2 (de) | Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen | |
DE69115920D1 (de) | Verfahren zur Behandlung von schmelzgeblasenen Filamenten | |
DE3856398D1 (de) | Verfahren zur Behandlung von Gleitkörpern | |
DE69307509D1 (de) | Vorrichtung zur behandlung von herzfehlern | |
DE69008820D1 (de) | Verfahren zur Behandlung von Polymerisaten. | |
DE69109560D1 (de) | Fungizide Zusammensetzung zur Behandlung von Saatgut. | |
DE69102552D1 (de) | Verfahren zur Behandlung von Fasermaterialien. | |
ATE267180T1 (de) | Phosphorderivate zur behandlung von aids | |
DE69534701D1 (de) | Verfahren zur behandlung von entzündlichen gelenkerkrankungen | |
ATE198751T1 (de) | Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen | |
DE69807466T2 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
DE69737067D1 (de) | Vakzine zur behandlung von mycosen | |
DE59009344D1 (de) | Verfahren zur Behandlung von Polyolefinfolien. | |
DE69936994D1 (de) | Verfahren zur behandlung von okularen neovaskularen erkrankungen | |
ATE261434T1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
DE59102745D1 (de) | Verfahren une einrichtung zur behandlung von saatgut. | |
DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
DE69607559D1 (de) | Verfahren zur Behandlung von Phenolteer | |
NO913117D0 (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
DE68903208D1 (de) | Verfahren zur thermischen behandlung von laktoferrin. | |
PT87368A (pt) | Verfahren zur biologischen behandlung stickstoffbelasteter abwaessar | |
DE69408394T2 (de) | 4-Piperidino-piperidin zur Behandlung von Tumoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |